MEETINGS - Seminar on Managing Your EC Business to Facilitate US Market Entry (UK) October 1998:
This article was originally published in Clinica
Executive Summary
A seminar on Managing Your EC Business to Facilitate US Market Entry will take place in London on October 5. The meeting will be attended by representatives from the Association of British Health-Care Industries, Washington DC-based law firm Hogan & Hartson and MedPass International, a consulting firm specialising in medical device regulatory affairs. Topics include the FDA and its current attitude towards device approvals, mutual recognition and globalisation and managing product liability risks. Contact Victoria Price in the UK for more details. Tel: +44 171 628 2020. Fax: +44 171 628 2070.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
England’s NICE Says No To Santhera’s DMD Drug Agamree Due To ‘Unreliable Modeling’
Santhera Pharmaceuticals did not provide enough evidence to demonstrate that its Duchenne muscular dystrophy drug Agamree was a cost-effective use of resources, according to draft guidance from England’s health technology assessment body, NICE.